Online citations, reference lists, and bibliographies.

Specific Splice Variants Are Associated With Parkinson's Disease.

José A. Santiago, C. Scherzer, J. Potashkin
Published 2013 · Medicine, Biology

Cite This
Download PDF
Analyze on Scholarcy
BACKGROUND Diagnosis of Parkinson's disease (PD) currently relies on assessment of motor symptoms. Recently, sensitive, specific, and readily available splice variant-specific biomarkers were identified in peripheral blood from participants in the Diagnostic and Prognostic Biomarkers in Parkinson Disease study. METHODS Here we test for an association between candidate splice variant biomarkers and PD in blood of an independent population of cases and controls nested in the Harvard NeuroDiscovery Center Biomarker Study. RESULTS Expression of 7 out of 13 candidate biomarkers was dysregulated in whole cellular blood of patients with PD. CONCLUSIONS These results support the view that differential expression of a subset of splice-variant markers in blood is associated with PD. Further evaluation in untreated, de novo patients and at-risk subjects is warranted.
This paper references
The GeneMANIA prediction server: biological network integration for gene prioritization and predicting gene function
David Warde-Farley (2010)
Endothelial Surface N-Glycans Mediate Monocyte Adhesion and Are Targets for Anti-inflammatory Effects of Peroxisome Proliferator-activated Receptor γ Ligands*
Balu K. Chacko (2011)
A molecular signature in blood identifies early Parkinson’s disease
L. Molochnikov (2012)
Molecular markers of early Parkinson's disease based on gene expression in blood
C. Scherzer (2007)
JNK Expression by Macrophages Promotes Obesity-Induced Insulin Resistance and Inflammation
M. S. Han (2013)
PGC-1α, A Potential Therapeutic Target for Early Intervention in Parkinson’s Disease
B. Zheng (2010)
PPAR‐gamma‐mediated neuroprotection in a chronic mouse model of Parkinson’s disease
Nicoletta Schintu (2009)
Disruption of the Jnk2 (Mapk9) gene reduces destructive insulitis and diabetes in a mouse model of type I diabetes.
A. Jaeschke (2005)
Association of SNCA with Parkinson: replication in the Harvard NeuroDiscovery Center Biomarker Study.
H. Ding (2011)
Biosignatures for Parkinson’s Disease and Atypical Parkinsonian Disorders Patients
J. Potashkin (2012)
Shared dysregulated pathways lead to Parkinson's disease and diabetes.
José A. Santiago (2013)
Exon Arrays Reveal Alternative Splicing Aberrations in Parkinson’s Disease Leukocytes
L. Soreq (2011)

This paper is referenced by
Upgraded Methodology for the Development of Early Diagnosis of Parkinson’s Disease Based on Searching Blood Markers in Patients and Experimental Models
A. Kim (2018)
Mining genetic and transcriptomic data using machine learning approaches in Parkinson’s disease
Chang Su (2020)
Current Challenges Towards the Development of a Blood Test for Parkinson’s Disease
José A. Santiago (2014)
Evaluation of RNA Blood Biomarkers in the Parkinson’s Disease Biomarkers Program
José A. Santiago (2018)
Integrative transcriptomic meta-analysis of Parkinson’s disease and depression identifies NAMPT as a potential blood biomarker for de novo Parkinson’s disease
José A. Santiago (2016)
Assessment of brain reference genes for RT-qPCR studies in neurodegenerative diseases
Rasmus Rydbirk (2016)
Integrative analysis of blood metabolomics and PET brain neuroimaging data for Parkinson's disease
E. Glaab (2019)
Evaluation of RNA Blood Biomarkers in Individuals at Risk of Parkinson's Disease.
José A. Santiago (2017)
Splicing: is there an alternative contribution to Parkinson’s disease?
Valentina La Cognata (2015)
A network approach to clinical intervention in neurodegenerative diseases.
José A. Santiago (2014)
Blood Biomarkers Associated with Cognitive Decline in Early Stage and Drug-Naive Parkinson’s Disease Patients
José A. Santiago (2015)
Network-based metaanalysis identifies HNF4A and PTBP1 as longitudinally dynamic biomarkers for Parkinson’s disease
José A. Santiago (2015)
A network approach to diagnostic biomarkers in progressive supranuclear palsy.
José A. Santiago (2014)
Network Analysis Identifies SOD2 mRNA as a Potential Biomarker for Parkinson's Disease
José A. Santiago (2014)
Computational systems biology approaches for Parkinson’s disease
E. Glaab (2017)
Reply to Toker and Pavlidis: Blood biomarkers for Parkinson’s disease
José A. Santiago (2015)
Integrative Network Analysis Unveils Convergent Molecular Pathways in Parkinson's Disease and Diabetes
José A. Santiago (2013)
Semantic Scholar Logo Some data provided by SemanticScholar